Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...

A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

The process of separating useful molecules from mixtures of other substances accounts for 15% of the nation's energy, emits ...

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...